Show simple item record

dc.contributor.authorLorigan, Paul C
dc.contributor.authorEggermont, A
dc.date.accessioned2019-08-05T12:24:41Z
dc.date.available2019-08-05T12:24:41Z
dc.date.issued2019en
dc.identifier.citationLorigan P, Eggermont AMM. Anti-PD1 treatment of advanced melanoma: development of criteria for a safe stop. Ann Oncol. 2019.en
dc.identifier.pmid31218362en
dc.identifier.doi10.1093/annonc/mdz182en
dc.identifier.urihttp://hdl.handle.net/10541/621931
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdz182en
dc.titleAnti-PD1 treatment of advanced melanoma: development of criteria for a safe stopen
dc.typeArticleen
dc.contributor.departmentDivision of Cancer Sciences, University of Manchester and Christie NHS Foundation Trust, Manchester, UKen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record